Ostroff GR - Search Results

1

A comparison of the pulmonary inflammatory potential of different components of yeast cell wall.

Young SH, Ostroff GR, Zeidler-Erdely PC, Roberts JR, Antonini JM, Castranova V. Young SH, et al. Among authors: ostroff gr. J Toxicol Environ Health A. 2007 Jul;70(13):1116-24. doi: 10.1080/15287390701212224. J Toxicol Environ Health A. 2007. PMID: 17558806

2

Exploiting fungal cell wall components in vaccines.

Levitz SM, Huang H, Ostroff GR, Specht CA. Levitz SM, et al. Among authors: ostroff gr. Semin Immunopathol. 2015 Mar;37(2):199-207. doi: 10.1007/s00281-014-0460-6. Epub 2014 Nov 18. Semin Immunopathol. 2015. PMID: 25404118 Free PMC article. Review.

3

Preparation and characterization of yeast cell wall beta-glucan encapsulated humic acid nanoparticles as an enhanced aflatoxin B₁ binder.

Hamza Z, El-Hashash M, Aly S, Hathout A, Soto E, Sabry B, Ostroff G. Hamza Z, et al. Carbohydr Polym. 2019 Jan 1;203:185-192. doi: 10.1016/j.carbpol.2018.08.047. Epub 2018 Aug 12. Carbohydr Polym. 2019. PMID: 30318202

4

Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.

Specht CA, Lee CK, Huang H, Hester MM, Liu J, Luckie BA, Torres Santana MA, Mirza Z, Khoshkenar P, Abraham A, Shen ZT, Lodge JK, Akalin A, Homan J, Ostroff GR, Levitz SM. Specht CA, et al. Among authors: ostroff gr. mBio. 2017 Nov 28;8(6):e01872-17. doi: 10.1128/mBio.01872-17. mBio. 2017. PMID: 29184017 Free PMC article.

5

Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.

Hester MM, Lee CK, Abraham A, Khoshkenar P, Ostroff GR, Levitz SM, Specht CA. Hester MM, et al. Among authors: ostroff gr. Vaccine. 2020 Jan 16;38(3):620-626. doi: 10.1016/j.vaccine.2019.10.051. Epub 2019 Nov 4. Vaccine. 2020. PMID: 31699504 Free PMC article.

6

Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.

Specht CA, Lee CK, Huang H, Tipper DJ, Shen ZT, Lodge JK, Leszyk J, Ostroff GR, Levitz SM. Specht CA, et al. Among authors: ostroff gr. mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15. mBio. 2015. PMID: 26695631 Free PMC article.

7

A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens.

Abraham A, Ostroff G, Levitz SM, Oyston PCF. Abraham A, et al. Clin Exp Immunol. 2019 Nov;198(2):143-152. doi: 10.1111/cei.13356. Epub 2019 Sep 12. Clin Exp Immunol. 2019. PMID: 31400225 Free PMC article. Review.

8

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

Mirza Z, Soto ER, Dikengil F, Levitz SM, Ostroff GR. Mirza Z, et al. Among authors: ostroff gr. Methods Mol Biol. 2017;1625:143-157. doi: 10.1007/978-1-4939-7104-6_11. Methods Mol Biol. 2017. PMID: 28584989

9

Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.

Deepe GS Jr, Buesing WR, Ostroff GR, Abraham A, Specht CA, Huang H, Levitz SM. Deepe GS Jr, et al. Among authors: ostroff gr. Vaccine. 2018 May 31;36(23):3359-3367. doi: 10.1016/j.vaccine.2018.04.047. Epub 2018 May 2. Vaccine. 2018. PMID: 29729993 Free PMC article.

10

Cross-reactivity between vaccine antigens from the chitin deacetylase protein family improves survival in a mouse model of cryptococcosis.

Hester MM, Oliveira LVN, Wang R, Mou Z, Lourenco D, Ostroff GR, Specht CA, Levitz SM. Hester MM, et al. Among authors: ostroff gr. Front Immunol. 2022 Sep 28;13:1015586. doi: 10.3389/fimmu.2022.1015586. eCollection 2022. Front Immunol. 2022. PMID: 36248898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page